MEMBER LOGIN: Your Email: Password: Remember Me
Forgot Your Password or would like to register?
MDT Medtronic
As Of 6/19/2018 8:04:00 AM
Current Price$86.25
Current Rating2
Return Since 7/2015
Medtronic23.41 %
S&P 50034.35 %
VFS Rating Analysis
VFS
Rating
Data
points
Monthly
Return
Market ReturnAverage
return vs market
223.81%1.47%2.33%
Related Links
Company News
Earnings Call Transcripts
Options Chain
Options Pricing History
For current estimates, historical performance information and more, Log in to your account.

Monthly Performance and Prediction History
Below is the monthly performance history for this security and the monthly change as compared to the stock market for this security. When a row is highlighted in green, it is identifying a stock that the model predict will outperform the portfolio for that month. When a row is highlighted in red, it is identifying a stock that the model predicted will underperform for the month. No highlight indicates the model is neutral on the stock. These predictions are always recorded at the beginning of the month, and table below shows the resulting return for the month.
DateVFS RatingPredictionRating PriceSubsequent
Month
% Increase
Subsequent
Month
Market %
Increase *
Return
vs
market
6-01-20182 $86.32   
5-01-20182Underperform$80.137.72%2.43%5.29%
4-01-20182 $80.22-0.11%0.52%-0.63%
* As measured by the performance of the S&P 500 for the month.

RECENT COMPANY NEWS
SymbolsWt.TitleDate
MDT13Medtronic's Expanded IN.PACT Admiral FDA Nod to Aid APV Arm (finance.yahoo.com)6/18/2018 3:01:00 PM
MDT13Free Pre-Market Technical Recap on MiMedx Group and Three Additional Medical Equipment Stocks (finance.yahoo.com)6/18/2018 4:20:00 AM
MDT13Medtronic Receives FDA Approval for 200mm & 250mm IN.PACT(TM) Admiral(TM) Drug Coated Balloons (finance.yahoo.com)6/15/2018 5:31:00 AM
MDT13Medtronic ActivaProgramming Application Wins FDA Nod for DBS (finance.yahoo.com)6/14/2018 8:33:00 AM
MDT13Medtronic Launches New Clinician Programmer for Deep Brain Stimulation Therapy (finance.yahoo.com)6/13/2018 4:01:00 AM
MDT13Artificial Pancreas Lifts Tandem Diabetes (finance.yahoo.com)6/13/2018 12:41:00 AM
MDT13Medtronic's (MDT) CRHF Arm Growth Strong, Rising Costs a Woe (finance.yahoo.com)6/5/2018 7:48:00 AM
MDT13Major Drivers of Medtronic’s Restorative Therapies Segment (finance.yahoo.com)6/5/2018 4:32:00 AM
MDT13Medtronic Presents Strategic Growth Roadmap at 2018 Investor Day; Outlines Plan to Create Shareholder Value (finance.yahoo.com)6/5/2018 3:46:00 AM
SYK, MDT8Zacks Industry Outlook Highlights: Boston Scientific, Stryker, Medtronic, Abbott and Varian Medical (finance.yahoo.com)6/18/2018 4:28:00 AM
MDT8AI And Robotics Are Taking Robotic Surgery To New Levels (finance.yahoo.com)6/12/2018 2:26:00 PM
MDT8Want To Invest In Medtronic plc (NYSE:MDT)? Here’s How It Performed Lately (finance.yahoo.com)6/8/2018 7:36:00 AM
MDT8Better Buy: Intuitive Surgical, Inc. vs. Medtronic PLC (finance.yahoo.com)6/6/2018 8:46:00 AM
MDT8Medtronic: Cramer's Top Takeaways (finance.yahoo.com)6/6/2018 3:24:00 AM
MDT8Medtronic CEO: Our new 'artificial pancreas' tech can hel... (finance.yahoo.com)6/5/2018 4:14:00 PM
MDT8The Zacks Analyst Blog Highlights: Visa, Medtronic, Salesforce, Dollar General and Martin Marietta (finance.yahoo.com)6/5/2018 6:11:00 AM
MDT8Medtronic’s Key Growth Driver: MiniMed 670G Hybrid Closed Loop (finance.yahoo.com)6/5/2018 6:02:00 AM
MDT35 AI Biotech Stocks to Bet On Now (finance.yahoo.com)6/14/2018 10:42:00 AM
MDT3DexCom Stock History (finance.yahoo.com)6/13/2018 4:24:00 PM
MDT3Boston Scientific Up on Possible Takeover Bid by Stryker (finance.yahoo.com)6/12/2018 7:15:00 AM
MDT3Boston Scientific Corporation Stock Surges on Potential Stryker Takeover (finance.yahoo.com)6/11/2018 10:47:00 AM
MDT3Cramer Remix: What the bullish moves in retail signal for... (finance.yahoo.com)6/5/2018 4:07:00 PM
MDT3Cramer Remix: What the bullish moves in retail signal for the American consumer (finance.yahoo.com)6/5/2018 4:00:00 PM
MDT210 Undervalued Low-Volatility Stocks (finance.yahoo.com)6/5/2018 3:00:00 AM

WEBSITE DISCLAIMER:  Puget Investors and Vertical Financial Systems, Inc are not registered investment advisers, broker/dealers, or research analysts/organizations. The content on this website is issued solely for information purposes and should not to be construed as an offer to buy, sell, or trade in any way, any security mentioned herein.

All information presented on this website is believed to be reliable and written in good faith, but no representation or warranty, expressed or implied is made as to their accuracy, completeness or correctness. You are responsible for doing your own research before investing in any securities mentioned herein. Readers are urged to consult with their own independent financial advisors with respect to any investment. Neither Vertical Financial Systems, Inc, nor its officers or employees accept any liability whatsoever for any direct or consequential loss arising from any use of information on this website.

Past performance is not a guarantee of future performance or accuracy. Rating calculations and methodology may change at any time, and we reserve the right to make changes which may impact the accuracy of the model without prior notice to anybody.

Be advised that employees and officers of Vertical Financial Systems, Inc and Pugetinvestor.com may hold positions in the securities mentioned in this website.
Website Operated by Vertical Financial Systems, Inc